Image

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Researching treatments for kids with certain Wilms tumors.

Recruiting
30 years and younger
All
Phase 3

This study is for children with a type of kidney cancer called Wilms Tumor. The goal is to use risk factors to decide the best treatment for them. Wilms Tumor is a common kidney cancer in kids, and "favorable histology" means the cancer cells look less aggressive. The study aims to find ways to prevent the cancer from coming back after treatment. The treatments might include surgery, chemotherapy, and sometimes radiation. The study checks if some treatments are as good as past ones but with fewer side effects.

  • Participation: Requires frequent visits and tests, with follow-ups for 10 years.
  • Eligibility: Children under 30 years with newly diagnosed Wilms Tumor.
  • Treatment: Involves different chemotherapy drugs depending on tumor stage and biology.

This study does not involve patients with Stage V Wilms Tumor. Risks include side effects from chemotherapy. It’s important for families to understand the commitment before joining. Participants will help researchers learn more about which treatments work best for different patients.

Study details
    Stage I Mixed Cell Type Kidney Wilms Tumor
    Stage II Mixed Cell Type Kidney Wilms Tumor
    Stage III Mixed Cell Type Kidney Wilms Tumor
    Stage IV Mixed Cell Type Kidney Wilms Tumor

NCT06401330

Children's Oncology Group

7 March 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.